Belhaven Biopharma to Present Promising Phase 1 Data on Needle-Free Epinephrine Powder at ACAAI Annual Meeting
Phase 1 results demonstrate rapid absorption and response profile, highlighting Nasdepi® as an innovative alternative for emergency allergy treatment RALEIGH, NC / ACCESSWIRE / October 24, 2024 / Belhaven Biopharma,…
